Outcome of Board Meeting held on Thursday, July 30, 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Date: 30th July, 2026 The Listing Compliance Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400001. Subject: Outcome of Board Meeting held on Thursday, July 30, 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Ref.: Norris Medicines Limited, Script Code: 524414, ISIN: INE744C01029. Dear Sir/ Madam, On recommendation of Audit Committee and the Nomination and Remuneration Committee, pursuant to provisions of Section 203 of the Companies Act, 2013 read with rules made there under and SEBI LODR Regulations, the Board of Directors in their meeting held today i.e., 30th July, 2026, approved appointment of Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) and KMP of the Company w.e.f. 30th July, 2026. The details required under Regulation 30 of the Listing Regulations read with applicable SEBI Circular(s) in respect of appointment of CFO and KMP, are enclosed herewith as Annexure A. Board meeting’s commencement time: 5:00 PM Board meeting’s concluded time: 5:30 PM Kindly take the note of the above and acknowledge the receipt of the same. For NORRIS MEDICINES LIMITED VIMAL D. SHAH DIRECTOR DIN-01506655 Annexure A Details with respect to Regulation 30 read with Schedule Ill of the Listing Regulations, SEBI Circular SEBI Circular bearing Ref. No. SEBI/HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026 Name of the Chief Financial Officer Mr. Iqubal Ismail Patel Reason for change Viz appointment, Appointment as Chief Financial Officer Resignation, removal, death or of the Company. otherwise Date of Appointment /re- Date of Appointment: 30th July, 2026 appointment/cessation (as applicable) & term of appointment/re-appointment Term of appointment: Mr. Iqubal Ismail Patel on such terms and condition including remuneration as may be mutually agreed between Mr. Iqubal Ismail Patel and the board of directors of the Company Brief profile (In case of appointment) Mr. Iqubal Ismail Patel has been associated with Norris Medicines Ltd for more than past 11 years and possesses rich experience in finance, accounts, taxation, budgeting, financial planning, and corporate management. He has played a significant role in the Company's financial operations and strategic initiatives in past. Mr. Iqbal Patel holds a Graduate degree. Disclosure of relationship between He is not related to any of the Directors Directors (in case of appointment) and Key Managerial Personnel of the Company. Confirmation in compliance with SEBI NA. Letter dated June 14, 2018 read along with Exchange Circular dated June 20, 2018 (Affirmation that the person proposed to be appointed as Director is not debarred from holding the office by virtue of any SEBI Order or any other authority) Affirmation that the Director being NA. appointed is not disqualified from holding the office of director pursuant to provisions of Section 164 of the Companies Act, 2013 For NORRIS MEDICINES LIMITED VIMAL D. SHAH DIRECTOR DIN-01506655